Streetbeat News

Analyst Ratings

AEYE

HC Wainwright & Co. analyst Scott Buck maintains a Buy rating on AudioEye (NASDAQ:AEYE) and raises the price target from $23 to $28.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:11 am

INCY

Wolfe Research has initiated coverage on Incyte with an Outperform rating, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 10:06 am

CATX

Wedbush analyst David Nierengarten has initiated coverage on Perspective Therapeutics (AMEX:CATX) with an Outperform rating and set a price target of $25.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:58 am

TMO

Stephens & Co. has initiated coverage on Thermo Fisher Scientific with an Overweight rating and set a price target of $680.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:53 am

ERX

FENY

IAT

KBE

KRE

RWR

SCHH

USRT

XLE

Bank of America highlights real estate, financials, and energy as value sectors benefiting from the Fed's dual stimulus of rate cuts and rising corporate profits. ETFs like USRT, SCHH, RWR, KRE, IAT, KBE, ERX, FENY, and XLE are notable performers in these sectors.

Portfolio Pulse from Kaustubh Bagalkote

October 01, 2024 | 9:50 am

DHR

Stephens & Co. has initiated coverage on Danaher (NYSE:DHR) with an Overweight rating and set a price target of $315.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:48 am

GRTS

JMP Securities has downgraded Gritstone Bio from Market Outperform to Market Perform, indicating a less favorable outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:38 am

RMD

Needham analyst Mike Matson has reiterated a Hold rating on ResMed (NYSE:RMD).

Portfolio Pulse from Benzinga Newsdesk

October 01, 2024 | 9:31 am

DELL

NVDA

Michael Dell has sold $1.2 billion worth of Dell Technologies stock, reducing his stake amid the company's recent S&P 500 relisting and AI expansion. This sale follows positive analyst coverage and a strong year-to-date stock performance.

Portfolio Pulse from Kaustubh Bagalkote

October 01, 2024 | 3:56 am

TSLA

Wedbush analyst Dan Ives anticipates Tesla's upcoming robotaxi event to be a 'seminal and historical day' for the company, with potential game-changing updates on autonomous technology. Ives maintains an Outperform rating and a $300 price target for Tesla, highlighting the significance of the event for Tesla's growth in AI and autonomous driving.

Portfolio Pulse from Adam Eckert

September 30, 2024 | 10:26 pm